ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |